Racial Differences in False-positive Mammogram Rates

Medical Care

Volumn 53, Issue 8, 2015, Pages 673-678

  McCarthy, Anne Marie ^a   Yamartino, Philip ^b   Yang, Jianing ^b   Bristol, Mirar ^a   Conant, Emily F ^c   Armstrong, Katrina ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Department of Medicine ^*  (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

African American; black; false positive; mammography; race

Indexed keywords

ADULT; ARTICLE; BIRTH CONTROL; BREAST BIOPSY; BREAST CANCER; BREAST DENSITY; CANCER RISK; CANCER SCREENING; COHORT ANALYSIS; CONTROLLED STUDY; DIGITAL MAMMOGRAPHY; ESTROGEN THERAPY; FEMALE; FOLLOW UP; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MENARCHE; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE DIFFERENCE; AFRICAN AMERICAN; BREAST TUMOR; CAUCASIAN; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; ETHNOLOGY; MAMMOGRAPHY; MASS SCREENING; PROCEDURES; RADIOGRAPHY; STATISTICS AND NUMERICAL DATA;

ADULT; AFRICAN AMERICANS; BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED;

EID: 84937938828     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.0000000000000393     Document Type: Article

References (48)

1. Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer: an update for the US Preventive Services Task Force. Ann Intern Med. 2009;151:727-737. W237-42.
2. Hubbard RA, Kerlikowske K, Flowers CI, et al. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med. 2011;155:481-492.
3. Brodersen J, Siersma VD. Long-term psychosocial consequences of falsepositive screening mammography. Ann Fam Med. 2013;11:106-115.
4. Chubak J, Boudreau DM, Fishman PA, et al. Cost of breast-related care in the year following false positive screening mammograms. Med Care. 2010;48:815-820.
5. Force USPST. Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151:716-726. W-236.
6. Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care (full printed version). Washington, D.C.: The National Academies Press; 2003.
7. Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol. 2012;137:516-542.
8. Carney PA, Miglioretti DL, Yankaskas BC, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med. 2003;138:168-175.
9. Kerlikowske K, Zhu W, Hubbard RA, et al. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med. 2013;173:807-816.
10. Taplin S, Abraham L, Barlow WE, et al. Mammography facility characteristics associated with interpretive accuracy of screening mammography. J Natl Cancer Inst. 2008;100:876-887.
11. Elmore JG, Jackson SL, Abraham L, et al. Variability in interpretive performance at screening mammography and radiologists' characteristics associated with accuracy. Radiology. 2009;253:641-651.
12. Christiansen CL,Wang F, Barton MB, et al. Predicting the cumulative risk of false-positive mammograms. J Natl Cancer Inst. 2000;92:1657-1666.
13. Chang VW, Lauderdale DS. Fundamental cause theory, technological innovation, and health disparities: the case of cholesterol in the era of statins. J Health Soc Behav. 2009;50:245-260.
14. Stanley A, DeLia D, Cantor JC. Racial disparity and technology diffusion: the case of cardioverter defibrillator implants, 1996-2001. J Natl Med Assoc. 2007;99:201-207.
15. Groeneveld PW, Laufer SB, Garber AM. Technology diffusion, hospital variation, and racial disparities among elderly Medicare beneficiaries: 1989-2000. Med Care. 2005;43:320-329.
16. Crystal S, Sambamoorthi U, Merzel C. The diffusion of innovation in AIDS treatment: zidovudine use in two New Jersey cohorts. Health Serv Res. 1995;30:593-614.
17. Ferris TG, Kuhlthau K, Ausiello J, et al. Are minority children the last to benefit from a new technology? Technology diffusion and inhaled corticosteriods for asthma. Med Care. 2006;44:81-86.
18. Korda RJ, Clements MS, Dixon J. Socioeconomic inequalities in the diffusion of health technology: uptake of coronary procedures as an example. Soc Sci Med. 2011;72:224-229.
19. Albain KS, Unger JM, Crowley JJ, et al. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst. 2009;101:984-992.
20. Kapp JM, Walker R, Haneuse S, et al. Are there racial/ethnic disparities among women younger than 40 undergoing mammography? Breast Cancer Res Treat. 2010;124:213-222.
21. Goldman LE, Walker R, Miglioretti DL, et al. Facility characteristics do not explain higher false-positive rates in diagnostic mammography at facilities serving vulnerable women. Med Care. 2012;50:210-216.
22. Goldman LE, Walker R, Miglioretti DL, et al. Accuracy of diagnostic mammography at facilities serving vulnerable women. Med Care. 2011;49:67-75.
23. Rauscher GH, Conant EF, Khan JA, et al. Mammogram image quality as a potential contributor to disparities in breast cancer stage at diagnosis: an observational study. BMC Cancer. 2013;13:208.
24. Rauscher GH, Allgood KL, Whitman S, et al. Disparities in screening mammography services by race/ethnicity and health insurance. J Womens Health. 2012;21:154-160.
25. Jha AK, Orav EJ, Li Z, et al. Concentration and quality of hospitals that care for elderly black patients. Arch Intern Med. 2007;167:1177-1182.
26. Hasnain-Wynia R, Baker DW, Nerenz D, et al. Disparities in health care are driven by where minority patients seek care: examination of the hospital quality alliance measures. Arch Intern Med. 2007;167:1233-1239.
27. Barnato AE, Lucas FL, Staiger D, et al. Hospital-level racial disparities in acute myocardial infarction treatment and outcomes. Med Care. 2005;43:308-319.
28. Skinner J, Chandra A, Staiger D, et al. Mortality after acute myocardial infarction in hospitals that disproportionately treat black patients. Circulation. 2005;112:2634-2641.
29. Pippins JR, Fitzmaurice GM, Haas JS. Hospital characteristics and racial disparities in hospital mortality from common medical conditions. J Natl Med Assoc. 2007;99:1030-1036.
30. Pisano ED, Gatsonis CA, Yaffe MJ, et al. American College of Radiology Imaging Network Digital Mammographic Imaging Screening Trial: objectives and methodology. Radiology. 2005;236:404-412.
31. Pisano ED, Gatsonis C, Hendrick E, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 2005;353:1773-1783.
32. Hubbard RA, Zhu W, Onega TL, et al. Effects of digital mammography uptake on downstream breast-related care among older women. Med Care. 2012;50:1053-1059.
33. Henderson LM, Hubbard RA, Onega TL, et al. Assessing health care use and cost consequences of a new screening modality: the case of digital mammography. Med Care. 2012;50:1045-1052.
34. Gill KS, Yankaskas BC. Screening mammography performance and cancer detection among black women and white women in community practice. Cancer. 2004;100:139-148.
35. Yankaskas BC, Gill KS. Diagnostic mammography performance and race: outcomes in Black and White women. Cancer. 2005;104:2671-2681.
36. O'Meara ES, Zhu W, Hubbard RA, et al. Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age. Cancer. 2013;119:3959-3967.
37. Miglioretti DL, Smith-Bindman R, Abraham L, et al. Radiologist characteristics associated with interpretive performance of diagnostic mammography. J Natl Cancer Inst. 2007;99:1854-1863.
38. Elmore JG, Miglioretti DL, Reisch LM, et al. Screening mammograms by community radiologists: variability in false-positive rates. J Natl Cancer Inst. 2002;94:1373-1380.
39. Yankaskas BC, May RC, Matuszewski J, et al. Effect of observing change from comparison mammograms on performance of screening mammography in a large community-based population. Radiology. 2011;261:762-770.
40. Burnside ES, Sickles EA, Sohlich RE, et al. Differential value of comparison with previous examinations in diagnostic versus screening mammography. AJR Am J Roentgenol. 2002;179:1173-1177.
41. Callaway MP, Boggis CR, Astley SA, et al. The influence of previous films on screening mammographic interpretation and detection of breast carcinoma. Clin Radiol. 1997;52:527-529.
42. Roelofs AA, Karssemeijer N, Wedekind N, et al. Importance of comparison of current and prior mammograms in breast cancer screening. Radiology. 2007;242:70-77.
43. Thurfjell MG, Vitak B, Azavedo E, et al. Effect on sensitivity and specificity of mammography screening with or without comparison of old mammograms. Acta Radiol. 2000;41:52-56.
44. Brewer NT, Salz T, Lillie SE. Systematic review: the long-term effects of false-positive mammograms. Ann Intern Med. 2007;146: 502-510.
45. DeFrank J, Brewer NT. Some more evidence of long-term psychosocial harms from receiving false-positive screening mammography results. Evid Based Med. 2014;19:38.
46. Consedine NS. A false-positive on screening mammography has a negative psychosocial impact up to 3 years after receiving the all clear. Evid Based Ment Health. 2013;16:115.
47. Armstrong K, Moye E, Williams S, et al. Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians. Ann Intern Med. 2007;146:516-526.
48. Tiro JA, Meissner HI, Kobrin S, et al. What do women in the US know about human papillomavirus and cervical cancer? Cancer Epidemiol Biomarkers Prev. 2007;16:288-294.